Control of Guanine Exchange Factor Activity Using De Novo Designed Protein Inhibitors
Biorxiv : the Preprint Server for Biology
|June 4, 2026
Summary
Researchers engineered novel protein inhibitors to precisely control Guanine Exchange Factor (GEF) activity in living cells. This generative protein design platform offers new tools for studying intracellular signaling pathways.
Area of Science:
- Molecular Biology
- Cell Signaling
- Protein Engineering
Background:
- Guanine Exchange Factors (GEFs) activate RhoA GTPases, crucial for cellular processes.
- Understanding GEF function requires studying their activity in real-time within living cells.
- Existing tools lack the speed and reversibility needed for dynamic GEF modulation.
Purpose of the Study:
- To develop a versatile platform for engineering specific inhibitors against Dbl family GEFs.
- To create tools for rapid and reversible modulation of endogenous GEF activity in live cells.
- To demonstrate the utility of generative protein design for creating intracellular signaling modulators.
Main Methods:
- Utilized generative protein design to engineer high-affinity, specific inhibitors for Dbl family GEFs.
- Validated inhibitor efficacy both in vitro and in cellular environments.
- Implemented optogenetic control by coupling a GEF inhibitor to a light-activated module.
Main Results:
- Engineered proteins demonstrated high affinity and specificity for target GEFs.
- Modulation of GEF activity was confirmed both in vitro and within living cells.
- Successful optogenetic control of GEF activity was achieved using a light-activated inhibitor.
Conclusions:
- Generative protein design is a powerful approach for creating specific modulators of intracellular signaling pathways.
- The developed platform expands the toolkit for studying GEF and GTPase biology in real-time.
- This work enables new avenues for investigating cellular signaling dynamics and developing targeted therapeutics.


